Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

5902 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
71-9 / Fresenius Medical Care Deutschland GmbH Original drug not imported to China Approved in EU The 71st Batch of Reference Listed Drugs
71-10 / Fresenius Medical Care Deutschland GmbH Original drug not imported to China Approved in EU The 71st Batch of Reference Listed Drugs
71-11     / Fresenius Medical Care Deutschland GmbH Original drug not imported to China Approved in EU The 71st Batch of Reference Listed Drugs
71-12     / Fresenius Medical Care Deutschland GmbH Original drug not imported to China Approved in EU The 71st Batch of Reference Listed Drugs
71-13     Carmubris Tillomed Pharma GmbH Original drug not imported to China Approved in EU The 71st Batch of Reference Listed Drugs
71-14     / Tillomed Laboratories Ltd Original drug not imported to China Approved in UK The 71st Batch of Reference Listed Drugs
71-15     Femoston conti Mylan Products Ltd. Original drug not imported to China Approved in UK The 71st Batch of Reference Listed Drugs
71-16     Carnitor Alfasigma S.p.A Original drug not imported to China Approved in UK The 71st Batch of Reference Listed Drugs
71-17     OXAROL Injection Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社) Original drug not imported to China Approved in Japan The 71st Batch of Reference Listed Drugs
71-18     OXAROL Injection Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社) Original drug not imported to China Approved in Japan The 71st Batch of Reference Listed Drugs